SlateStone Wealth LLC Purchases 138 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

SlateStone Wealth LLC boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,176 shares of the medical equipment provider’s stock after acquiring an additional 138 shares during the quarter. SlateStone Wealth LLC’s holdings in Intuitive Surgical were worth $2,180,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Atala Financial Inc bought a new stake in Intuitive Surgical in the 4th quarter valued at $25,000. Berbice Capital Management LLC bought a new stake in Intuitive Surgical during the 4th quarter worth about $26,000. BankPlus Trust Department bought a new stake in Intuitive Surgical during the 4th quarter worth about $28,000. Kohmann Bosshard Financial Services LLC bought a new stake in Intuitive Surgical during the 4th quarter worth about $31,000. Finally, MidAtlantic Capital Management Inc. bought a new stake in Intuitive Surgical during the 3rd quarter worth about $33,000. 83.64% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on ISRG shares. Bernstein Bank boosted their price target on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research report on Monday, January 27th. Royal Bank of Canada boosted their price objective on shares of Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Stifel Nicolaus boosted their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, December 5th. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their price objective for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. Finally, BTIG Research boosted their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research note on Tuesday, November 26th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Stock Up 1.6 %

NASDAQ ISRG opened at $484.44 on Friday. The company has a market capitalization of $172.55 billion, a P/E ratio of 75.58, a P/E/G ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The firm has a 50-day moving average price of $567.46 and a two-hundred day moving average price of $531.60.

Insider Transactions at Intuitive Surgical

In related news, EVP Robert Desantis sold 11,545 shares of the stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the transaction, the executive vice president now owns 5,224 shares of the company’s stock, valued at $2,607,925.28. This represents a 68.85 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 33,754 shares of company stock valued at $17,691,621. Company insiders own 0.90% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.